3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
8
Withdrawn
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
17
Glioblastoma
8
Esophageal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Oropharyngeal Neoplasms
7
Breast Neoplasms
7
Mouth Neoplasms
6
Glioma
6
Triple Negative Breast Neoplasms
4
Lung Neoplasms
4
Laryngeal Neoplasms
4
Head and Neck Neoplasms
4
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Neuroblastoma
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Medulloblastoma
2
Hypopharyngeal Neoplasms
2
Ganglioneuroblastoma
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Radiotherapy
3
Nivolumab
3
pembrolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Paclitaxel
2
ONC206
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
Biopsy
2
regorafenib
1
pegfilgrastim
1
mirdametinib
1
lutetium Lu 177 dotatate
1
fludarabine
1
etoposide phosphate
1
entrectinib
1
entinostat
1
elacestrant
1
decitabine and cedazuridine drug combination
1
cabozantinib
1
amino-acid, glucose, and electrolyte solution
1
alectinib
1
aflibercept
1
abemaciclib
1
Topotecan
1
Tissue Banks
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Central Nervous System Neoplasms
×
Radiation
×
Clear all
NCT04732065
2026-03-17
PNOC023
University of California, San Francisco
Phase 1
Recruiting
208 enrolled